Inhibition of brain cholinesterases (AChE and BChE) by potential inhibitors reinstates the level of ACh and, thus, plays an important role in the treatment of AD, Dementia, and Parkinson’s disease [3] and the consequences of cholinesterases inhibition are assessed by observing cholinergically mediated processes such as cognition [4]. This evidence concerns the gene ACHE and dementia.